Ralph Arlinghaus.
- Published in:
- 2002
- Publication type:
- Editorial
Works matching IS 09509232 AND DT 2002 AND VI 21 AND IP 56
Results: 15
1
2
The basis of t-cell-mediated immunity to chronic myelogenous leukemia.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8668, doi. 10.1038/sj.onc.1206093
- By:
- Publication type:
- Article
3
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8652, doi. 10.1038/sj.onc.1206094
- By:
- Publication type:
- Article
4
Studying the pathogenesis of BCR-ABL[sup+] leukemia in mice.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8643, doi. 10.1038/sj.onc.1206091
- By:
- Publication type:
- Article
5
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8629, doi. 10.1038/sj.onc.1206090
- By:
- Publication type:
- Article
6
The biology of chronic myelogenous leukemia: mouse models and cell adhesion.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8612, doi. 10.1038/sj.onc.1206089
- By:
- Publication type:
- Article
7
Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ABL-induced defects in integrin function in CML.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8605, doi. 10.1038/sj.onc.1206088
- By:
- Publication type:
- Article
8
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8591, doi. 10.1038/sj.onc.1206087
- By:
- Publication type:
- Article
9
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8584, doi. 10.1038/sj.onc.1206086
- By:
- Publication type:
- Article
10
Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8577, doi. 10.1038/sj.onc.1206085
- By:
- Publication type:
- Article
11
Transforming pathways activated by the v-Abl tyrosine kinase.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8568, doi. 10.1038/sj.onc.1206084
- By:
- Publication type:
- Article
12
Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8560, doi. 10.1038/sj.onc.1206083
- By:
- Publication type:
- Article
13
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8547, doi. 10.1038/sj.onc.1206082
- By:
- Publication type:
- Article
14
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8541, doi. 10.1038/sj.onc.1206081
- By:
- Publication type:
- Article
15
Philadelphia-positive leukemia: a personal perspective.
- Published in:
- Oncogene, 2002, v. 21, n. 56, p. 8536, doi. 10.1038/sj.onc.1206080
- By:
- Publication type:
- Article